A significant advance in cancer investigation is arising with the use of nanobodies to re-engage damaged p53. This crucial cancer inhibitor protein is frequently inactivated in various kinds of cancer, leading https://meshbookmarks.com/story22052181/vhh-fragments-revive-tumor-suppressor-p53-the-new-approach-for-malignant-management